ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

DMTR Deepmatter Group Plc

0.0325
0.00 (0.00%)
09 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Deepmatter Group Plc LSE:DMTR London Ordinary Share GB00B29YYY86 ORD 0.01P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.0325 0.025 0.04 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

DeepMatter Group PLC DeepMatter Appoints Industry Advisors

16/12/2019 7:01am

RNS Non-Regulatory


TIDMDMTR

DeepMatter Group PLC

16 December 2019

DeepMatter Group plc

("DeepMatter", the "Company" or "the Group")

DeepMatter Appoints Industry Advisors

DeepMatter strengthens its depth of knowledge and industry links in Research & Medicinal Chemistry, Process Chemistry and Automation

16 December 2019 - DeepMatter (AIM: DMTR), the AIM-quoted company focusing on digitising chemistry, is delighted to welcome three leading sector figures as industry advisors on its commercial roll-out of DigitalGlassware(TM). The advisors bring in-depth knowledge in research & medicinal chemistry, process chemistry and industrially focused closed-loop robotics and automation, all target industries for DigitalGlassware(TM), the Company's innovative cloud-based digital chemistry platform that brings recordability, reproducibility and shareability to the lab.

The advisors will contribute to the ongoing development of the DigitalGlassware(TM) strategic roadmap and are as follows:

-- Dr Richard Bourne - a leading academic in Process Chemistry. Richard is Associate Professor at the University of Leeds based at the Institute of Process Research and Development, working on rapid process development and continuous flow chemistry. In November 2019, he was announced as a new Royal Academy of Engineering Senior Research Fellow in Digital Manufacturing and Discovery of Pharmaceuticals.

-- Dr John Harris - a pharmaceutical industry consultant with a wealth of research chemistry knowledge and expertise. John was previously Head of the Wellcome Foundation's UK cardiovascular therapeutic area and founder of BioFocus, a highly successful early-stage CRO, now part of the Charles River organisation.

-- Dr David M Parry - an experienced synthetic chemist, with a track record of delivering complex projects within the pharma and biotech sectors. David built and ran a business focused on automated medicinal chemistry, where compounds would be synthesised, then tested in a primary assay on the same platforms, with the results fed back into the software to inform the next round of automated synthesis.

Mark Warne, Chief Executive Officer of DeepMatter, commented:

"We believe DigitalGlassware(TM) has the opportunity to sit at the heart of the digitisation of chemistry, enabling chemists to produce better molecules, faster and ultimately cheaper. We are delighted to welcome Richard, John and David to the DigitalGlassware(TM) team, each bringing valuable insight from their three areas of specialism. Their expertise will help ensure the platform meets and integrates the needs of these key disciplines, assisting us in the commercial roll-out of our innovative cloud-based digital chemistry platform."

For more information, please contact:

 
 DeepMatter Group plc                    T: 0141 548 8156 
 Mark Warne, Chief Executive Officer 
 
  Shore Capital (Nominated Adviser and 
   Broker)                                 T: 020 7408 4050 
 Tom Griffiths 
  David Coaten 
 
 Alma PR                                 T: 020 3405 0205 
  Caroline Forde                          deepmatter@almapr.co.uk 
  Jessica Joynson 
  Kieran Breheny 
 

About DeepMatter Group plc

DeepMatter's long term strategy is to integrate chemistry with technology, thereby enabling a greater use of artificial intelligence and reaching a point where chemicals can be autonomously synthesised through robotics. In the near term this involves the provision of an integrated software, hardware and artificial intelligence enabled platform, DigitalGlassware(TM), to scientists across research and process development sectors.

The DigitalGlassware(TM) platform allows chemistry experiments to be accurately and systematically recorded, coded and entered into a shared data cloud. The platform is designed to enable chemists to work together effectively; sharing the details of their experiments from anywhere and in real-time, so that work is not needlessly duplicated, time and money wasted, and ultimately so new discoveries may be made faster.

Visit: www.deepmatter.io and follow @deepmattergroup

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NRAMMMMZNFZGLZM

(END) Dow Jones Newswires

December 16, 2019 02:01 ET (07:01 GMT)

1 Year Deepmatter Chart

1 Year Deepmatter Chart

1 Month Deepmatter Chart

1 Month Deepmatter Chart

Your Recent History

Delayed Upgrade Clock